Phase 2 Discovery, Inc.

Phase 2 Discovery (P2D) is a pharmaceutical company focused on developing innovative drugs that fulfill unmet medical needs in the treatment of central nervous system (CNS) disorders such as insomnia, anxiety, depression, attention disorders and neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS).
At P2D, we are using our understanding of the treatment of CNS disorders and neurodegenerative diseases and our experienced team to efficiently build a product portfolio of therapeutics with a greater likelihood for clinical success. Our goal is to advance a product candidate through clinical proof of concept by producing powerful and compelling clinical data and then seeking partners to complete development and commercialization.

Contact Details: 3130 Highland Ave Cincinnati Ohio 45219 United States of America Tel: (513) 475-6618 Fax: (513) 221-1891 Email: jmulchahey@phase2D.com WWW: www.phase2d.com/

Loading...

BioNews Results for Phase 2 Discovery, Inc.:
Drug Resistance: Studies from Pfizer Inc. update current data on drug resistance	NewsRX:  Oct 21 2009 12:14PM Matching: phase 2 discovery inc

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 384 times since April 2007, the link to the organisation's website has been followed 100 times

Recent Search Terms used to find this page: phase 2 dis | .

Search for more companies in Cincinnati

Search for more companies in Ohio

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Phase 2 Discovery, Inc.